Profile data is unavailable for this security.
About the company
STERIS plc is a provider of products and services that support patient care with an emphasis on infection prevention. The Company’s segments include Healthcare, Applied Sterilization Technologies, Life Sciences and Dental. The Healthcare segment is focused on sterile processing departments and procedural centers, such as operating rooms and endoscopy suites. Its Applied Sterilization Technologies (AST) segment is a third-party service provider for contract sterilization, as well as testing services needed to validate sterility services for medical device and pharmaceutical manufacturers. Its Life Sciences segment provides a comprehensive offering of products and services that support pharmaceutical manufacturing, primarily for vaccine and other biopharma customers focused on aseptic manufacturing. Its Dental segment provides a comprehensive offering for dental practitioners and dental schools, offering instruments, infection prevention consumables and instrument management systems.
- Revenue in USD (TTM)5.41bn
- Net income in USD566.84m
- Incorporated2016
- Employees17.00k
- LocationSTERIS plcBlock a Riverside IV70 Sir John Rogerson's QuayDUBLIN 2IrelandIRL
- Phone+353 12322000
- Websitehttps://www.steris.com/
Mergers & acquisitions
| Acquired company | STE:NYQ since announced | Transaction value |
|---|---|---|
| Becton Dickinson & Co-Surgical Instrumentation Assets | -6.09% | 540.00m |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Insulet Corp | 1.70bn | 206.30m | 11.64bn | 3.00k | 59.00 | 15.86 | 41.71 | 6.86 | 2.82 | 2.82 | 22.78 | 10.48 | 0.7014 | 1.43 | 6.00 | 565,700.00 | 8.53 | 2.71 | 10.26 | 3.14 | 68.35 | 65.81 | 12.16 | 4.28 | 2.62 | 40.74 | 0.659 | 0.00 | 30.02 | 24.66 | 4,384.78 | 128.77 | -7.63 | -- |
| Shockwave Medical Inc | 730.23m | 147.28m | 12.28bn | 1.47k | 84.87 | 18.12 | 77.92 | 16.82 | 3.86 | 3.86 | 19.13 | 18.08 | 0.66 | 1.04 | 7.86 | 497,431.90 | 13.31 | 10.29 | 14.40 | 11.39 | 86.94 | 84.69 | 20.17 | 15.14 | 10.73 | 19.70 | 0.5226 | 0.00 | 49.11 | 126.45 | -31.81 | -- | 72.88 | -- |
| Hologic Inc | 3.97bn | 515.10m | 17.59bn | 6.99k | 35.62 | 3.78 | 20.91 | 4.43 | 2.10 | 2.10 | 16.13 | 19.84 | 0.447 | 2.70 | 5.90 | 567,854.10 | 5.80 | 11.40 | 6.48 | 13.38 | 55.44 | 60.29 | 12.98 | 20.95 | 3.18 | -- | 0.3565 | 0.00 | -17.12 | 4.61 | -64.98 | -- | 7.30 | -- |
| Cooper Companies Inc | 3.67bn | 290.80m | 17.86bn | 15.00k | 90.81 | 2.32 | 26.83 | 4.87 | 0.9896 | 0.9896 | 7.36 | 38.73 | 0.3108 | 1.77 | 5.95 | 244,420.00 | 2.47 | 10.06 | 2.68 | 11.34 | 66.09 | 65.54 | 7.93 | 29.00 | 1.08 | 4.92 | 0.2649 | 0.3469 | 8.61 | 7.24 | -23.74 | -3.66 | 15.18 | 31.95 |
| Steris PLC | 5.41bn | 566.84m | 19.79bn | 17.00k | 35.31 | 3.08 | 17.34 | 3.66 | 5.67 | 5.67 | 54.18 | 64.93 | 0.4864 | 3.94 | 6.05 | 318,081.40 | 5.11 | 3.99 | 5.54 | 4.37 | 43.60 | 43.41 | 10.50 | 7.90 | 1.49 | 6.42 | 0.3399 | 49.05 | 8.13 | 13.61 | -56.12 | -17.02 | 16.95 | 8.74 |
| Baxter International Inc | 14.81bn | -76.00m | 20.13bn | 60.00k | -- | 2.39 | 16.86 | 1.36 | -0.1508 | 5.22 | 29.23 | 16.55 | 0.5238 | 3.43 | 5.48 | 246,883.30 | -0.244 | 0.1942 | -0.3054 | 0.2333 | 35.89 | 38.20 | -0.4658 | 0.3674 | 1.04 | 3.28 | 0.6197 | 1,398.94 | 2.12 | 5.94 | 97.15 | -- | 0.982 | 9.71 |
| Align Technology, Inc. | 3.86bn | 445.05m | 22.59bn | 21.61k | 51.62 | 6.21 | 38.45 | 5.85 | 5.81 | 5.81 | 50.43 | 48.36 | 0.642 | 3.64 | 4.38 | 178,725.60 | 7.40 | 16.34 | 11.07 | 24.14 | 70.08 | 71.72 | 11.52 | 23.16 | 1.04 | -- | 0.00 | 0.00 | 3.42 | 14.45 | 23.09 | 2.15 | -4.46 | -- |
| Zimmer Biomet Holdings Inc | 7.39bn | 1.02bn | 24.92bn | 18.00k | 24.81 | 2.00 | 12.61 | 3.37 | 4.89 | 4.89 | 35.26 | 60.70 | 0.3475 | 0.9195 | 5.24 | 410,794.40 | 4.82 | 2.21 | 5.49 | 2.52 | 71.82 | 71.25 | 13.86 | 7.28 | 0.7784 | 7.32 | 0.316 | 38.90 | 6.55 | -1.40 | 252.86 | -- | 9.44 | 0.00 |
| Resmed Inc | 4.50bn | 890.39m | 25.57bn | 10.14k | 28.80 | 5.70 | 23.87 | 5.68 | 6.04 | 6.04 | 30.53 | 30.47 | 0.6633 | 2.10 | 6.17 | 444,189.10 | 13.11 | 13.59 | 14.74 | 15.89 | 55.11 | 56.98 | 19.77 | 19.22 | 1.89 | 19.64 | 0.2149 | 36.66 | 18.02 | 12.53 | 15.15 | 14.63 | 13.40 | 4.68 |
| West Pharmaceutical Services Inc. | 2.95bn | 593.40m | 27.62bn | 10.60k | 47.87 | 9.63 | 38.74 | 9.36 | 7.88 | 7.88 | 39.19 | 39.20 | 0.7923 | 4.29 | 5.79 | 278,283.00 | 15.46 | 15.61 | 18.41 | 18.65 | 38.28 | 38.06 | 19.52 | 18.47 | 2.24 | -- | 0.067 | 10.69 | 2.18 | 11.43 | 2.28 | 23.76 | 28.16 | 6.20 |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Dec 2023 | 11.45m | 11.59% |
| BlackRock Fund Advisorsas of 31 Dec 2023 | 5.93m | 6.00% |
| Massachusetts Financial Services Co.as of 31 Dec 2023 | 5.81m | 5.88% |
| WCM Investment Management LLCas of 31 Dec 2023 | 4.85m | 4.91% |
| SSgA Funds Management, Inc.as of 31 Dec 2023 | 4.24m | 4.29% |
| APG Asset Management NVas of 31 Dec 2023 | 3.62m | 3.66% |
| Morgan Stanley Investment Management Ltd.as of 31 Dec 2023 | 2.84m | 2.88% |
| Geode Capital Management LLCas of 31 Dec 2023 | 2.18m | 2.21% |
| Janus Henderson Investors US LLCas of 31 Dec 2023 | 1.99m | 2.01% |
| T. Rowe Price Associates, Inc. (Investment Management)as of 31 Dec 2023 | 1.48m | 1.50% |
